These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 9395464)

  • 41. Postprandial exchange of apolipoprotein C-III between plasma lipoproteins.
    Barr SI; Kottke BA; Mao SJ
    Am J Clin Nutr; 1981 Feb; 34(2):191-8. PubMed ID: 7211723
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL.
    Berbée JF; van der Hoogt CC; Sundararaman D; Havekes LM; Rensen PC
    J Lipid Res; 2005 Feb; 46(2):297-306. PubMed ID: 15576844
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors.
    Gordts PL; Nock R; Son NH; Ramms B; Lew I; Gonzales JC; Thacker BE; Basu D; Lee RG; Mullick AE; Graham MJ; Goldberg IJ; Crooke RM; Witztum JL; Esko JD
    J Clin Invest; 2016 Aug; 126(8):2855-66. PubMed ID: 27400128
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase.
    Takahashi S; Suzuki J; Kohno M; Oida K; Tamai T; Miyabo S; Yamamoto T; Nakai T
    J Biol Chem; 1995 Jun; 270(26):15747-54. PubMed ID: 7797576
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
    Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibitory effect on the lipolysis-stimulated receptor of the 39-kDa receptor-associated protein.
    Troussard AA; Khallou J; Mann CJ; André P; Strickland DK; Bihain BE; Yen FT
    J Biol Chem; 1995 Jul; 270(29):17068-71. PubMed ID: 7615497
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overexpression of apolipoprotein E3 in transgenic rabbits causes combined hyperlipidemia by stimulating hepatic VLDL production and impairing VLDL lipolysis.
    Huang Y; Ji ZS; Brecht WJ; Rall SC; Taylor JM; Mahley RW
    Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2952-9. PubMed ID: 10591675
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolism of C-apolipoproteins: kinetics of C-II, C-III1 and C-III2, and VLDL-apolipoprotein B in normal and hyperlipoproteinemic subjects.
    Huff MW; Fidge NH; Nestel PJ; Billington T; Watson B
    J Lipid Res; 1981 Nov; 22(8):1235-46. PubMed ID: 7320634
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
    Murdoch SJ; Breckenridge WC
    Atherosclerosis; 1995 Dec; 118(2):193-212. PubMed ID: 8770314
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Studies on the binding and degradation of human very-low-density lipoproteins by human hepatoma cell line HepG2.
    Dashti N; Wolfbauer G
    Biochim Biophys Acta; 1986 Feb; 875(3):473-86. PubMed ID: 3004589
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Abnormal activation of lipoprotein lipase by non-equilibrating apoC-II: further evidence for the presence of non-equilibrating pools of apolipoproteins C-II and C-III in plasma lipoproteins.
    Tornoci L; Scheraldi CA; Li X; Ide H; Goldberg IJ; Le NA
    J Lipid Res; 1993 Oct; 34(10):1793-803. PubMed ID: 8245727
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Apolipoprotein C-III can specifically bind to hepatic plasma membranes.
    Fang DZ; Liu BW
    Mol Cell Biochem; 2000 Apr; 207(1-2):57-64. PubMed ID: 10888227
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Overexpression of human apolipoprotein C-III in transgenic mice results in an accumulation of apolipoprotein B48 remnants that is corrected by excess apolipoprotein E.
    de Silva HV; Lauer SJ; Wang J; Simonet WS; Weisgraber KH; Mahley RW; Taylor JM
    J Biol Chem; 1994 Jan; 269(3):2324-35. PubMed ID: 8294490
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Distribution of seven ApoC-III glycoforms in plasma, VLDL, IDL, LDL and HDL of healthy subjects.
    Rodríguez M; Rehues P; Iranzo V; Mora J; Balsells C; Guardiola M; Ribalta J
    J Proteomics; 2022 Jan; 251():104398. PubMed ID: 34688878
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human intestinal lipoproteins. Studies in chyluric subjects.
    Green PH; Glickman RM; Saudek CD; Blum CB; Tall AR
    J Clin Invest; 1979 Jul; 64(1):233-42. PubMed ID: 221544
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatic binding of triglyceride-rich lipoproteins in humans.
    Florén CH
    Scand J Clin Lab Invest; 1985 Oct; 45(6):531-7. PubMed ID: 2999965
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Triglyceride-rich lipoprotein metabolism in women: roles of apoC-II and apoC-III.
    Ooi EM; Chan DC; Hodson L; Adiels M; Boren J; Karpe F; Fielding BA; Watts GF; Barrett PH
    Eur J Clin Invest; 2016 Aug; 46(8):730-6. PubMed ID: 27378472
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of insulin in lipoprotein secretion by cultured rat hepatocytes.
    Patsch W; Franz S; Schonfeld G
    J Clin Invest; 1983 May; 71(5):1161-74. PubMed ID: 6343434
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes in the plasma lipoprotein distribution of apolipoproteins C-II, C-III1, C-III2 and apolipoprotein B after heparin-induced lipolysis.
    Nestel PJ; Huff MW; Billington T; Fidge NH
    Biochim Biophys Acta; 1982 Jul; 712(1):94-102. PubMed ID: 7115750
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice.
    Jong MC; Rensen PC; Dahlmans VE; van der Boom H; van Berkel TJ; Havekes LM
    J Lipid Res; 2001 Oct; 42(10):1578-85. PubMed ID: 11590213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.